Company Comparison
Minoryx Therapeutics vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Minoryx Therapeutics | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | Lagos, Nigeria |
| Founded | — | 2019 |
| Status | Active | Active |
| Last Funding Stage | — | Series B |
| Total Funding | — | $45M |
| Valuation | — | — |
What They Build
Minoryx Therapeutics
Biopharmaceutical company developing treatments for rare neurological diseases and CNS disorders.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
Minoryx Therapeutics
Sector Overlap
Both Minoryx Therapeutics and 54gene operate in Biotech.
Browse all Biotech companies →Websites
Sponsored
AArchstone
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
LP portal & reportingCapital callsPortfolio tracking$297/moNo AUM fees
Now in alpha with select funds. 14-day trial available.